Search

Search Constraints

You searched for: Author/Creator Manos, Michael

Search Results

1. 648 Cytokine changes during immune-related adverse events and steroid treatment in melanoma patients receiving immune checkpoint inhibitors. (9th November 2020)

2. 481 Impact of COVID-19 on Cancer Patients Receiving Immune Checkpoint Inhibitors. (10th December 2020)

3. 481 Impact of COVID-19 on Cancer Patients Receiving Immune Checkpoint Inhibitors. (9th November 2020)

4. Distinct predictive biomarker candidates for response to anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients. Issue 1 (6th March 2018)

5. Characterization of genetics in patients with mucosal melanoma treated with immune checkpoint blockade. (15th March 2021)

6. Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition. Issue 1 (19th January 2021)

7. Vitamin D intake is associated with decreased risk of immune checkpoint inhibitor‐induced colitis. Issue 16 (22nd June 2020)

8. Novel platform leveraging electronic medical record (EMR) to triage patients admitted with high-grade immune-related adverse events (irAEs) to the immune-toxicity (ITOX) service. Issue 2 (18th August 2020)

9. Pneumonitis resulting from radiation and immune checkpoint blockade illustrates characteristic clinical, radiologic and circulating biomarker features. Issue 1 (24th April 2019)

10. 808 Exploring resistance mechanism to pembrolizumab and ang-2 inhibitor trebananib (NCT03239145) using high-dimensional single-cell mass cytometry (CyTOF). (10th December 2020)